APO Research
Talk to an analyst

APO RESEARCH · REPORT

Automatic Insulin Dosing Device

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Automatic Insulin Dosing Device Industry Growth and Trends Forecast to 2032

4 July 2026104 pages

Choose your research edition.

Industry ResearchAutomatic Insulin Dosing Device Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Automatic Insulin Dosing Device Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Automatic Insulin Dosing Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automatic Insulin Dosing Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Automatic Insulin Dosing Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Automatic Insulin Dosing Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Automatic Insulin Dosing Device include Admetsys, Beta Bionics, Bigfoot Biomedical, Defymed, Dexcom, Insulet, Micro Tech Medical, Tandem Diabetes Care and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Automatic Insulin Dosing Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Automatic Insulin Dosing Device market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Automatic Insulin Dosing Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Automatic Insulin Dosing Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Automatic Insulin Dosing Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Automatic Insulin Dosing Device Market by Company

Admetsys

Beta Bionics

Bigfoot Biomedical

Defymed

Dexcom

Insulet

Micro Tech Medical

Tandem Diabetes Care

Medtronic

Abbott

Automatic Insulin Dosing Device Segment by Type

Threshold Suspended Device Systems

Hybrid Closed-loop APDS

Other

Automatic Insulin Dosing Device Segment by Application

Hospital

Clinic

Home Care

Others

Automatic Insulin Dosing Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dosing Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dosing Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dosing Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Automatic Insulin Dosing Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Automatic Insulin Dosing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Threshold Suspended Device Systems Table 2. Major Company of Hybrid Closed-loop APDS Table 3. Major Company of Other Table 4. Global Automatic Insulin Dosing Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Automatic Insulin Dosing Device Sales by Type (2021-2026) & (k units) Table 6. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Type (2021-2026) Table 7. Global Automatic Insulin Dosing Device Sales by Type (2021-2026) & (US$ Million) Table 8. Global Automatic Insulin Dosing Device Sales Market Share in Value by Type (2021-2026) Table 9. Global Automatic Insulin Dosing Device Price by Type (2021-2026) & (USD/unit) Table 10. Global Automatic Insulin Dosing Device Sales by Type (2027-2032) & (k units) Table 11. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Type (2027-2032) Table 12. Global Automatic Insulin Dosing Device Sales by Type (2027-2032) & (US$ Million) Table 13. Global Automatic Insulin Dosing Device Sales Market Share in Value by Type (2027-2032) Table 14. Global Automatic Insulin Dosing Device Price by Type (2027-2032) & (USD/unit) Table 15. North America Automatic Insulin Dosing Device Sales by Type (2021-2026) & (k units) Table 16. North America Automatic Insulin Dosing Device Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Automatic Insulin Dosing Device Sales by Type (2021-2026) & (k units) Table 18. Europe Automatic Insulin Dosing Device Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Automatic Insulin Dosing Device Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Automatic Insulin Dosing Device Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Automatic Insulin Dosing Device Sales by Type (2021-2026) & (k units) Table 22. Latin America Automatic Insulin Dosing Device Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Automatic Insulin Dosing Device Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Automatic Insulin Dosing Device Sales by Type (2021-2026) & (US$ Million) Table 25. Automatic Insulin Dosing Device Industry Trends Table 26. Automatic Insulin Dosing Device Industry Drivers Table 27. Automatic Insulin Dosing Device Industry Opportunities and Challenges Table 28. Automatic Insulin Dosing Device Industry Restraints Table 29. Global Automatic Insulin Dosing Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Automatic Insulin Dosing Device Revenue Market Share by Company (2021-2026) Table 31. Global Automatic Insulin Dosing Device Sales by Company (2021-2026) & (k units) Table 32. Global Automatic Insulin Dosing Device Sales Share by Company (2021-2026) Table 33. Global Automatic Insulin Dosing Device Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Automatic Insulin Dosing Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Automatic Insulin Dosing Device Major Company Production Sites and Headquarters Table 36. Global Automatic Insulin Dosing Device Company, Product Type & Application Table 37. Global Automatic Insulin Dosing Device Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Automatic Insulin Dosing Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Automatic Insulin Dosing Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Automatic Insulin Dosing Device Sales by Region (2021-2026) & (k units) Table 42. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Region (2021-2026) Table 43. Global Automatic Insulin Dosing Device Sales by Region (2021-2026) & (US$ Million) Table 44. Global Automatic Insulin Dosing Device Sales Market Share in Value by Region (2021-2026) Table 45. Global Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Automatic Insulin Dosing Device Sales by Region (2027-2032) & (k units) Table 47. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Region (2027-2032) Table 48. Global Automatic Insulin Dosing Device Sales by Region (2027-2032) & (US$ Million) Table 49. Global Automatic Insulin Dosing Device Sales Market Share in Value by Region (2027-2032) Table 50. Global Automatic Insulin Dosing Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Automatic Insulin Dosing Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Automatic Insulin Dosing Device Sales by Application (2021-2026) & (k units) Table 53. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Application (2021-2026) Table 54. Global Automatic Insulin Dosing Device Sales by Application (2021-2026) & (US$ Million) Table 55. Global Automatic Insulin Dosing Device Sales Market Share in Value by Application (2021-2026) Table 56. Global Automatic Insulin Dosing Device Price by Application (2021-2026) & (USD/unit) Table 57. Global Automatic Insulin Dosing Device Sales by Application (2027-2032) & (k units) Table 58. Global Automatic Insulin Dosing Device Sales Market Share in Volume by Application (2027-2032) Table 59. Global Automatic Insulin Dosing Device Sales by Application (2027-2032) & (US$ Million) Table 60. Global Automatic Insulin Dosing Device Sales Market Share in Value by Application (2027-2032) Table 61. Global Automatic Insulin Dosing Device Price by Application (2027-2032) & (USD/unit) Table 62. North America Automatic Insulin Dosing Device Sales by Application (2021-2026) & (k units) Table 63. North America Automatic Insulin Dosing Device Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Automatic Insulin Dosing Device Sales by Application (2021-2026) & (k units) Table 65. Europe Automatic Insulin Dosing Device Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Automatic Insulin Dosing Device Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Automatic Insulin Dosing Device Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Automatic Insulin Dosing Device Sales by Application (2021-2026) & (k units) Table 69. Latin America Automatic Insulin Dosing Device Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Automatic Insulin Dosing Device Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Automatic Insulin Dosing Device Sales by Application (2021-2026) & (US$ Million) Table 72. Admetsys Company Information Table 73. Admetsys Business Overview Table 74. Admetsys Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Admetsys Automatic Insulin Dosing Device Product Portfolio Table 76. Admetsys Recent Development Table 77. Beta Bionics Company Information Table 78. Beta Bionics Business Overview Table 79. Beta Bionics Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Beta Bionics Automatic Insulin Dosing Device Product Portfolio Table 81. Beta Bionics Recent Development Table 82. Bigfoot Biomedical Company Information Table 83. Bigfoot Biomedical Business Overview Table 84. Bigfoot Biomedical Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Bigfoot Biomedical Automatic Insulin Dosing Device Product Portfolio Table 86. Bigfoot Biomedical Recent Development Table 87. Defymed Company Information Table 88. Defymed Business Overview Table 89. Defymed Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Defymed Automatic Insulin Dosing Device Product Portfolio Table 91. Defymed Recent Development Table 92. Dexcom Company Information Table 93. Dexcom Business Overview Table 94. Dexcom Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Dexcom Automatic Insulin Dosing Device Product Portfolio Table 96. Dexcom Recent Development Table 97. Insulet Company Information Table 98. Insulet Business Overview Table 99. Insulet Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Insulet Automatic Insulin Dosing Device Product Portfolio Table 101. Insulet Recent Development Table 102. Micro Tech Medical Company Information Table 103. Micro Tech Medical Business Overview Table 104. Micro Tech Medical Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Micro Tech Medical Automatic Insulin Dosing Device Product Portfolio Table 106. Micro Tech Medical Recent Development Table 107. Tandem Diabetes Care Company Information Table 108. Tandem Diabetes Care Business Overview Table 109. Tandem Diabetes Care Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Tandem Diabetes Care Automatic Insulin Dosing Device Product Portfolio Table 111. Tandem Diabetes Care Recent Development Table 112. Medtronic Company Information Table 113. Medtronic Business Overview Table 114. Medtronic Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Medtronic Automatic Insulin Dosing Device Product Portfolio Table 116. Medtronic Recent Development Table 117. Abbott Company Information Table 118. Abbott Business Overview Table 119. Abbott Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Abbott Automatic Insulin Dosing Device Product Portfolio Table 121. Abbott Recent Development Table 122. North America Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. North America Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 124. North America Automatic Insulin Dosing Device Sales Market Share by Country (2021-2026) Table 125. North America Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032) & (k units) Table 126. North America Automatic Insulin Dosing Device Sales Market Share Forecast by Country (2027-2032) Table 127. North America Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Automatic Insulin Dosing Device Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Automatic Insulin Dosing Device Market Share by Country (2021-2026) Table 130. North America Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Automatic Insulin Dosing Device Market Share Forecast by Country (2027-2032) Table 132. Europe Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Europe Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 134. Europe Automatic Insulin Dosing Device Sales Market Share by Country (2021-2026) Table 135. Europe Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032) & (k units) Table 136. Europe Automatic Insulin Dosing Device Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Automatic Insulin Dosing Device Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Automatic Insulin Dosing Device Market Share by Country (2021-2026) Table 140. Europe Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Automatic Insulin Dosing Device Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 144. Asia-Pacific Automatic Insulin Dosing Device Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032) & (k units) Table 146. Asia-Pacific Automatic Insulin Dosing Device Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Automatic Insulin Dosing Device Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Automatic Insulin Dosing Device Market Share by Country (2021-2026) Table 150. Asia-Pacific Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Automatic Insulin Dosing Device Market Share Forecast by Country (2027-2032) Table 152. Latin America Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Latin America Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 154. Latin America Automatic Insulin Dosing Device Sales Market Share by Country (2021-2026) Table 155. Latin America Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032) & (k units) Table 156. Latin America Automatic Insulin Dosing Device Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Automatic Insulin Dosing Device Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Automatic Insulin Dosing Device Market Share by Country (2021-2026) Table 160. Latin America Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Automatic Insulin Dosing Device Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 164. Middle East and Africa Automatic Insulin Dosing Device Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032) & (k units) Table 166. Middle East and Africa Automatic Insulin Dosing Device Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Automatic Insulin Dosing Device Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Automatic Insulin Dosing Device Market Share by Country (2021-2026) Table 170. Middle East and Africa Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Automatic Insulin Dosing Device Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Automatic Insulin Dosing Device Distributors List Table 175. Automatic Insulin Dosing Device Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Automatic Insulin Dosing Device Image Figure 2. Global Automatic Insulin Dosing Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automatic Insulin Dosing Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Automatic Insulin Dosing Device Sales (2021-2032) & (k units) Figure 5. Threshold Suspended Device Systems Image Figure 6. Global Threshold Suspended Device Systems Sales YoY Growth (2021-2032) & (k units) Figure 7. Hybrid Closed-loop APDS Image Figure 8. Global Hybrid Closed-loop APDS Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Automatic Insulin Dosing Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Automatic Insulin Dosing Device Market Share by Type 2025 VS 2032 Figure 13. North America Automatic Insulin Dosing Device Sales Market Share in Volume by Type in 2025 Figure 14. North America Automatic Insulin Dosing Device Sales Market Share in Value by Type in 2025 Figure 15. Europe Automatic Insulin Dosing Device Sales Market Share in Volume by Type in 2025 Figure 16. Europe Automatic Insulin Dosing Device Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Automatic Insulin Dosing Device Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Automatic Insulin Dosing Device Sales Market Share in Value by Type in 2025 Figure 19. Latin America Automatic Insulin Dosing Device Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Automatic Insulin Dosing Device Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Automatic Insulin Dosing Device Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Automatic Insulin Dosing Device Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Automatic Insulin Dosing Device Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 29. Home Care Image Figure 30. Global Home Care Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Automatic Insulin Dosing Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Automatic Insulin Dosing Device Market Share by Application 2025 VS 2032 Figure 35. North America Automatic Insulin Dosing Device Sales Market Share in Volume by Application in 2025 Figure 36. North America Automatic Insulin Dosing Device Sales Market Share in Value by Application in 2025 Figure 37. Europe Automatic Insulin Dosing Device Sales Market Share in Volume by Application in 2025 Figure 38. Europe Automatic Insulin Dosing Device Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Automatic Insulin Dosing Device Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Automatic Insulin Dosing Device Sales Market Share in Value by Application in 2025 Figure 41. Latin America Automatic Insulin Dosing Device Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Automatic Insulin Dosing Device Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Automatic Insulin Dosing Device Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Automatic Insulin Dosing Device Sales Market Share in Value by Application in 2025 Figure 45. North America Automatic Insulin Dosing Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Automatic Insulin Dosing Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Automatic Insulin Dosing Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Automatic Insulin Dosing Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Automatic Insulin Dosing Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Automatic Insulin Dosing Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Automatic Insulin Dosing Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Automatic Insulin Dosing Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Automatic Insulin Dosing Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Automatic Insulin Dosing Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Automatic Insulin Dosing Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Automatic Insulin Dosing Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Automatic Insulin Dosing Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Automatic Insulin Dosing Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Automatic Insulin Dosing Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Automatic Insulin Dosing Device Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Automatic Insulin Dosing Device Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Threshold Suspended Device Systems
  • Hybrid Closed-loop APDS
  • Other
Applications
  • Hospital
  • Clinic
  • Home Care
  • Others
Companies covered
  • Admetsys
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Dexcom
  • Insulet
  • Micro Tech Medical
  • Tandem Diabetes Care
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Automatic Insulin Dosing Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Automatic Insulin Dosing Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Automatic Insulin Dosing Device Market by Type
  6. 1.3.1 Threshold Suspended Device Systems
  7. 1.3.2 Hybrid Closed-loop APDS
  8. 1.3.3 Other
  9. 1.4 Global Automatic Insulin Dosing Device Market Size by Type
  10. 1.4.1 Global Automatic Insulin Dosing Device Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Automatic Insulin Dosing Device Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Automatic Insulin Dosing Device Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Automatic Insulin Dosing Device Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Automatic Insulin Dosing Device Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Automatic Insulin Dosing Device Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Automatic Insulin Dosing Device Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Automatic Insulin Dosing Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Automatic Insulin Dosing Device Industry Trends
  2. 2.2 Automatic Insulin Dosing Device Industry Drivers
  3. 2.3 Automatic Insulin Dosing Device Industry Opportunities and Challenges
  4. 2.4 Automatic Insulin Dosing Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Automatic Insulin Dosing Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Automatic Insulin Dosing Device Sales (2021-2026)
  3. 3.3 Global Top Players by Automatic Insulin Dosing Device Price (2021-2026)
  4. 3.4 Global Automatic Insulin Dosing Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Automatic Insulin Dosing Device Major Company Production Sites & Headquarters
  6. 3.6 Global Automatic Insulin Dosing Device Company, Product Type & Application
  7. 3.7 Global Automatic Insulin Dosing Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Automatic Insulin Dosing Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Automatic Insulin Dosing Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Automatic Insulin Dosing Device Tier 1, Tier 2, and Tier 3
4 Automatic Insulin Dosing Device Regional Status and Outlook
  1. 4.1 Global Automatic Insulin Dosing Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Automatic Insulin Dosing Device Historic Market Size by Region
  3. 4.2.1 Global Automatic Insulin Dosing Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Automatic Insulin Dosing Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Automatic Insulin Dosing Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Automatic Insulin Dosing Device Forecasted Market Size by Region
  7. 4.3.1 Global Automatic Insulin Dosing Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Automatic Insulin Dosing Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Automatic Insulin Dosing Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Automatic Insulin Dosing Device by Application
  1. 5.1 Automatic Insulin Dosing Device Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Home Care
  5. 5.1.4 Others
  6. 5.2 Global Automatic Insulin Dosing Device Market Size by Application
  7. 5.2.1 Global Automatic Insulin Dosing Device Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Automatic Insulin Dosing Device Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Automatic Insulin Dosing Device Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Automatic Insulin Dosing Device Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Automatic Insulin Dosing Device Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Automatic Insulin Dosing Device Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Automatic Insulin Dosing Device Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Automatic Insulin Dosing Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Admetsys
  2. 6.1.1 Admetsys Company Information
  3. 6.1.2 Admetsys Business Overview
  4. 6.1.3 Admetsys Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Admetsys Automatic Insulin Dosing Device Product Portfolio
  6. 6.1.5 Admetsys Recent Developments
  7. 6.2 Beta Bionics
  8. 6.2.1 Beta Bionics Company Information
  9. 6.2.2 Beta Bionics Business Overview
  10. 6.2.3 Beta Bionics Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beta Bionics Automatic Insulin Dosing Device Product Portfolio
  12. 6.2.5 Beta Bionics Recent Developments
  13. 6.3 Bigfoot Biomedical
  14. 6.3.1 Bigfoot Biomedical Company Information
  15. 6.3.2 Bigfoot Biomedical Business Overview
  16. 6.3.3 Bigfoot Biomedical Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bigfoot Biomedical Automatic Insulin Dosing Device Product Portfolio
  18. 6.3.5 Bigfoot Biomedical Recent Developments
  19. 6.4 Defymed
  20. 6.4.1 Defymed Company Information
  21. 6.4.2 Defymed Business Overview
  22. 6.4.3 Defymed Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Defymed Automatic Insulin Dosing Device Product Portfolio
  24. 6.4.5 Defymed Recent Developments
  25. 6.5 Dexcom
  26. 6.5.1 Dexcom Company Information
  27. 6.5.2 Dexcom Business Overview
  28. 6.5.3 Dexcom Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dexcom Automatic Insulin Dosing Device Product Portfolio
  30. 6.5.5 Dexcom Recent Developments
  31. 6.6 Insulet
  32. 6.6.1 Insulet Company Information
  33. 6.6.2 Insulet Business Overview
  34. 6.6.3 Insulet Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Insulet Automatic Insulin Dosing Device Product Portfolio
  36. 6.6.5 Insulet Recent Developments
  37. 6.7 Micro Tech Medical
  38. 6.7.1 Micro Tech Medical Company Information
  39. 6.7.2 Micro Tech Medical Business Overview
  40. 6.7.3 Micro Tech Medical Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Micro Tech Medical Automatic Insulin Dosing Device Product Portfolio
  42. 6.7.5 Micro Tech Medical Recent Developments
  43. 6.8 Tandem Diabetes Care
  44. 6.8.1 Tandem Diabetes Care Company Information
  45. 6.8.2 Tandem Diabetes Care Business Overview
  46. 6.8.3 Tandem Diabetes Care Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Tandem Diabetes Care Automatic Insulin Dosing Device Product Portfolio
  48. 6.8.5 Tandem Diabetes Care Recent Developments
  49. 6.9 Medtronic
  50. 6.9.1 Medtronic Company Information
  51. 6.9.2 Medtronic Business Overview
  52. 6.9.3 Medtronic Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Medtronic Automatic Insulin Dosing Device Product Portfolio
  54. 6.9.5 Medtronic Recent Developments
  55. 6.10 Abbott
  56. 6.10.1 Abbott Company Information
  57. 6.10.2 Abbott Business Overview
  58. 6.10.3 Abbott Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Abbott Automatic Insulin Dosing Device Product Portfolio
  60. 6.10.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Automatic Insulin Dosing Device Sales by Country
  2. 7.1.1 North America Automatic Insulin Dosing Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Automatic Insulin Dosing Device Sales by Country (2021-2026)
  4. 7.1.3 North America Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Automatic Insulin Dosing Device Market Size by Country
  6. 7.2.1 North America Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Automatic Insulin Dosing Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Automatic Insulin Dosing Device Sales by Country
  2. 8.1.1 Europe Automatic Insulin Dosing Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Automatic Insulin Dosing Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Automatic Insulin Dosing Device Market Size by Country
  6. 8.2.1 Europe Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Automatic Insulin Dosing Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Automatic Insulin Dosing Device Sales by Country
  2. 9.1.1 Asia-Pacific Automatic Insulin Dosing Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Automatic Insulin Dosing Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Automatic Insulin Dosing Device Market Size by Country
  6. 9.2.1 Asia-Pacific Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Automatic Insulin Dosing Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Automatic Insulin Dosing Device Sales by Country
  2. 10.1.1 South America Automatic Insulin Dosing Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Automatic Insulin Dosing Device Sales by Country (2021-2026)
  4. 10.1.3 South America Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Automatic Insulin Dosing Device Market Size by Country
  6. 10.2.1 South America Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Automatic Insulin Dosing Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Automatic Insulin Dosing Device Sales by Country
  2. 11.1.1 Middle East and Africa Automatic Insulin Dosing Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Automatic Insulin Dosing Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Automatic Insulin Dosing Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Automatic Insulin Dosing Device Market Size by Country
  6. 11.2.1 Middle East and Africa Automatic Insulin Dosing Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Automatic Insulin Dosing Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Automatic Insulin Dosing Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Automatic Insulin Dosing Device Value Chain Analysis
  2. 12.1.1 Automatic Insulin Dosing Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Automatic Insulin Dosing Device Production Mode & Process
  7. 12.2 Automatic Insulin Dosing Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Automatic Insulin Dosing Device Distributors
  10. 12.2.3 Automatic Insulin Dosing Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst